Indivior reported 3.69B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AstraZeneca USD 289.99B 11.26B Jun/2026
Cassava Sciences USD 82M 14M Mar/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Glaxosmithkline GBP 109.29B 9.36B Mar/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Roche Holding CHF 270B 3.66B Jun/2026
West Pharmaceutical Services USD 25.36B 7.3B Jun/2026